These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18332071)

  • 1. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
    Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G
    Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia.
    Onder AM; Billings A; Chandar J; Francoeur D; Simon N; Abitbol C; Zilleruelo G
    Nephrol Dial Transplant; 2010 Nov; 25(11):3686-93. PubMed ID: 20501464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.
    Onder AM; Chandar J; Simon N; Saint-Vil M; Francoeur D; Nwobi O; Abitbol C; Zilleruelo G
    Pediatr Nephrol; 2008 Mar; 23(3):457-64. PubMed ID: 18064496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters.
    Onder AM; Kato T; Simon N; Rivera-Hernandez M; Chandar J; Montane B; Francoeur D; Salvaggi G; Tzakis AG; Zilleruelo G
    Pediatr Transplant; 2007 Feb; 11(1):87-93. PubMed ID: 17239129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
    Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
    J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.
    Chow KM; Poon YL; Lam MP; Poon KL; Szeto CC; Li PK
    Hong Kong Med J; 2010 Aug; 16(4):269-74. PubMed ID: 20683069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
    Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
    J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.
    Onder AM; Chandar J; Billings A; Simon N; Gonzalez J; Francoeur D; Abitbol C; Zilleruelo G
    Pediatr Nephrol; 2009 Nov; 24(11):2233-43. PubMed ID: 19590902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-related bacteraemia in haemodialysis patients with HIV infection.
    Mitchell D; Krishnasami Z; Allon M
    Nephrol Dial Transplant; 2006 Nov; 21(11):3185-8. PubMed ID: 16891646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection associated with tunneled hemodialysis catheters.
    Beathard GA; Urbanes A
    Semin Dial; 2008; 21(6):528-38. PubMed ID: 19000122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter locks, heparin and biofilm: what is this the risk?
    Diskin CJ; Stokes TJ; Dansby L; Radcliff L; Carter TB
    Nephrol Dial Transplant; 2008 Aug; 23(8):2708-9. PubMed ID: 18544629
    [No Abstract]   [Full Text] [Related]  

  • 14. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
    Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
    APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
    Nori US; Manoharan A; Yee J; Besarab A
    Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
    Labriola L; Crott R; Jadoul M
    Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis.
    Onder AM; Chandar J; Coakley S; Abitbol C; Montane B; Zilleruelo G
    Pediatr Nephrol; 2006 Oct; 21(10):1452-8. PubMed ID: 16897007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing catheter-related infections in children undergoing hemodialysis.
    Stefanidis CJ
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1239-49. PubMed ID: 21073289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.
    Lemaire X; Morena M; Leray-Moragués H; Henriet-Viprey D; Chenine L; Defez-Fougeron C; Canaud B
    Blood Purif; 2009; 28(1):21-8. PubMed ID: 19325236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns.
    Onder AM; Billings AA; Chandar J; Nield L; Francoeur D; Simon N; Abitbol C; Zilleruelo G
    Hemodial Int; 2013 Jan; 17(1):75-85. PubMed ID: 22716190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.